Pharming Group N.V. (PHGUF)
OTCMKTS · Delayed Price · Currency is USD
1.300
+0.140 (12.07%)
At close: Aug 22, 2025
Pharming Group Revenue
Pharming Group had revenue of $93.22M in the quarter ending June 30, 2025, with 25.82% growth. This brings the company's revenue in the last twelve months to $339.84M, up 22.44% year-over-year. In the year 2024, Pharming Group had annual revenue of $297.20M with 21.15% growth.
Revenue (ttm)
339.84M
Revenue Growth
+22.44%
P/S Ratio
2.87
Revenue / Employee
841.18K
Employees
404
Market Cap
975.57M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 297.20M | 51.88M | 21.15% |
Dec 31, 2023 | 245.32M | 39.69M | 19.30% |
Dec 31, 2022 | 205.62M | 6.75M | 3.39% |
Dec 31, 2021 | 198.87M | -13.30M | -6.27% |
Dec 31, 2020 | 212.17M | 22.79M | 12.03% |
Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |
Pharming Group News
- 20 days ago - Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):... • news - Onvista
- 5 weeks ago - Pharming Group to participate in August investor conference - GlobeNewsWire
- 5 weeks ago - Pharming Group N.V. (PHAR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Pharming Group N.V. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Pharming Group N.V. GAAP EPS of $0.006, revenue of $93.2M - Seeking Alpha
- 5 weeks ago - Pharming Group reports second quarter and first half 2025 financial results and provides business update - GlobeNewsWire
- 7 weeks ago - Pharming Group to report second quarter and first half 2025 financial results and provide ... - GuruFocus
- 7 weeks ago - Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31 - GlobeNewsWire